Liquidity Mapping Around (ASTH) Price Events
This article provides an AI-generated analysis of Apollo Medical Holdings Inc. (NASDAQ: ASTH), indicating weak sentiment across all horizons and supporting a short bias. It details an exceptional 74.5:1 risk-reward setup targeting a 22.7% gain versus 0.3% risk. The report offers three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored to different risk profiles.
Astrana Health Inc. (ASTH) Stock Analysis: A Compelling 93% Upside Potential In Healthcare
Astrana Health Inc. (ASTH), a healthcare company formerly known as Apollo Medical Holdings, Inc., presents a compelling investment opportunity with a potential 93.05% upside based on analyst price targets. Despite a recent stock decline, its strong revenue growth of 99.70%, robust free cash flow, and an oversold RSI suggest a potential rebound. Analysts are largely bullish, with 9 buy ratings, indicating confidence in the company's future growth and strategic healthcare management initiatives.
Why (ASTH) Price Action Is Critical for Tactical Trading
This article analyzes Apollo Medical Holdings Inc. (NASDAQ: ASTH), highlighting weak sentiment across all time horizons supporting a short bias. It details institutional trading strategies, including long, breakout, and short positions with specific entry, target, and stop-loss levels, informed by AI-generated multi-timeframe signal analysis. The piece emphasizes a significant 78.2:1 risk-reward setup targeting a 23.6% gain against 0.3% risk.
Understanding Momentum Shifts in (ASTH)
This article analyzes Apollo Medical Holdings Inc. (NASDAQ: ASTH), highlighting a potential shift in positive near-term sentiment despite a broader weak alignment. It identifies a mid-channel oscillation pattern and an exceptional 67.7:1 risk-reward setup targeting a 19.0% gain. The piece also details AI-generated trading strategies and multi-timeframe signal analysis for various risk profiles.
Avoiding Lag: Real-Time Signals in (ASTH) Movement
This article provides a real-time analysis of Apollo Medical Holdings Inc. (NASDAQ: ASTH) using AI models to identify trading signals and strategies. It highlights a near-term weak sentiment that could test mid-term strength within a broader long-term weak bias, noting a significant risk-reward short setup. The analysis offers specific entry, target, and stop-loss levels for long, breakout, and short positions across different time horizons.
Discipline and Rules-Based Execution in ASTH Response
This article analyzes Apollo Medical Holdings Inc. (NASDAQ: ASTH), highlighting mixed sentiment and choppy conditions across horizons. It presents an exceptional 70.1:1 risk-reward setup targeting a 20.0% gain. The piece also details three AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—along with a multi-timeframe signal analysis for various holding periods.
(ASTH) Movement as an Input in Quant Signal Sets
This article analyzes Apollo Medical Holdings Inc. (NASDAQ: ASTH) using quantitative signals, highlighting near and mid-term strong sentiment but a weak long-term outlook. It identifies an exceptional 71.4:1 risk-reward setup targeting a 20.3% gain and provides three distinct trading strategies: Position Trading, Momentum Breakout, and Risk Hedging. The analysis includes multi-timeframe signal analysis with support and resistance levels, along with AI-generated signals.
(ASTH) Volatility Zones as Tactical Triggers
This article analyzes Apollo Medical Holdings Inc. (NASDAQ: ASTH), highlighting a near-term weak sentiment that may precede long-term weakness. It identifies a mid-channel oscillation pattern and presents an exceptional 71.6:1 risk-reward short setup. The piece details three AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored to different risk profiles.
Price-Driven Insight from (ASTH) for Rule-Based Strategy
This article provides a price-driven insight into Apollo Medical Holdings Inc. (NASDAQ: ASTH) for rule-based strategies, highlighting a near-term strong sentiment challenging persistent mid- and long-term weakness. It details an exceptional risk-reward short setup and outlines three distinct AI-generated trading strategies with specific entry, target, and stop-loss levels for different risk profiles.
(ASTH) as a Liquidity Pulse for Institutional Tactics
Stock Traders Daily provides an AI-driven analysis for Apollo Medical Holdings Inc. (NASDAQ: ASTH), highlighting a near-term weak sentiment that may lead to long-term weakness. The article details three institutional trading strategies—Position, Momentum Breakout, and Risk Hedging—alongside multi-timeframe signal analysis and specific risk-reward setups. Investors are offered real-time signals and personalized alerts to track ASTH's performance and risk.
Astrana Health (NASDAQ:ASTH) Posts Better-Than-Expected Sales In Q2, Stock Soars
Astrana Health (NASDAQ:ASTH) reported better-than-expected Q2 CY2025 revenue of $654.8 million, exceeding analyst estimates by 2.7% and showing a 34.7% year-over-year growth. The company also provided strong revenue guidance for the next quarter and full year, surpassing analyst expectations. Despite a miss on GAAP EPS, initial market reaction saw the stock trade up 5.1% immediately following the results.
Healthcare Technology for Providers Stocks Q1 Teardown: Astrana Health (NASDAQ:ASTH) Vs The Rest
This article analyzes the Q1 earnings performance of several healthcare technology for providers stocks, focusing on Astrana Health (NASDAQ:ASTH) as the weakest performer and Premier (NASDAQ:PINC) as the strongest. The sector generally experienced mixed results, with revenues beating estimates but overall share prices declining. The report also briefly touches on the current market update, noting recent rate cuts and all-time highs for major indices.
LA500 2025: Brandon Sim
Brandon Sim, CEO and President of Astrana Health, is recognized in the LA500 2025 list. He became sole chief executive last year, guiding Astrana Health's growth into a nationwide physician practice management company with over 10,000 affiliated providers. A significant move was the acquisition of Prospect Medical Holdings' managed care platform for approximately $745 million.
Astrana plots to expand its footprint with $745M deal for Prospect Health businesses
Astrana Health plans to acquire certain businesses and assets of Prospect Health System for $745 million, significantly expanding its provider care network across multiple states. This acquisition will add 610,000 value-based care lives to Astrana's platform, bringing its total to over 1.7 million members. The deal is expected to close in mid-2025 and will make Astrana one of the largest integrated care delivery and value-based care providers in the country.
Apollo Medical Holdings rebrands as Astrana Health
Apollo Medical Holdings, Inc. announced its rebranding to Astrana Health, Inc., effective February 26, 2024, with a new ticker symbol "ASTH." This change is part of the healthcare company's strategy to strengthen its identity and commitment to innovation within the healthcare industry. The rebranding will not affect the company's operations or headquarters, which will remain in Alhambra, California.
Apollo Medical Holdings, Inc. Becomes Astrana Health, Inc.
Apollo Medical Holdings, Inc. announced its formal name change to Astrana Health, Inc., effective February 26, 2024. The company will also begin trading under the new ticker symbol "ASTH" on the same date. This change reflects the company's continued focus as a provider-centric, technology-powered healthcare provider.
Apollo Medical Gets a New Name
Apollo Medical Holdings Inc. has rebranded as Astrana Health, effective February 26, to reflect its expanding national scope. Brandon Sim, previously co-chief executive, is now the sole chief executive after Thomas Lam's retirement from day-to-day operations. The company will also adopt a new Nasdaq stock symbol, ASTH.
Apollo Medical Holdings, Inc. Announces Planned Corporate Rebrand as Astrana Health
Apollo Medical Holdings, Inc. announced its plan to rebrand as Astrana Health, effective February 26, 2024, and its common stock will trade under the new NASDAQ symbol "ASTH." The rebranding reflects the company's expanding national footprint and commitment to delivering high-quality, value-based care to diverse communities nationwide, uniting its "star providers and teammates" under a new identity. Astrana Health, founded in 1992, serves approximately 900,000 members across various value-based care arrangements and partners with over 10,000 affiliated providers.
Apollo Medical Holdings, Inc. to Participate in Upcoming Investor Conference
Apollo Medical Holdings, Inc. announced its participation in the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024, at 1:30 p.m. PT. Leadership will present at the conference, and a webcast will be available on the company's website. ApolloMed is a leading provider-centric, technology-powered healthcare company focused on value-based care.
Apollo Medical Holdings, Inc. Announces Definitive Agreement to Acquire Assets of Community Family Care Medical Group IPA, Inc. and Health Plan
Apollo Medical Holdings, Inc. has announced a definitive agreement to acquire assets of Community Family Care Medical Group IPA, Inc., including its independent physician association, health plan, and management services organization entities. This acquisition is expected to significantly expand ApolloMed's value-based care platform in Los Angeles, particularly in the Medicaid market. The transaction, valued at $202 million, is anticipated to close in phases by the end of Q1 2024.
Apollo Medical Holdings, Inc. Announces Partnership with IntraCare to Advance Value-Based Care in Texas and Oklahoma
Apollo Medical Holdings, Inc. (ApolloMed) has partnered with IntraCare to enhance value-based care in Texas and Oklahoma. This collaboration aims to accelerate access to high-quality care for seniors, deploy ApolloMed's value-based care platform for IntraCare providers in the ACO REACH program, and support IntraCare's growth with a $25 million senior secured convertible promissory note.
Apollo Medical Holdings, Inc. Signs Definitive Agreement to Acquire Assets of Texas Independent Providers, Expanding Care Partners Business into Houston
Apollo Medical Holdings, Inc. announced a definitive agreement to acquire assets related to Texas Independent Providers, LLC (TIP), expanding ApolloMed's Care Partners business into Houston. This acquisition will integrate TIP's network of over 120 primary care providers and 4,500 Medicare Advantage patients into ApolloMed's value-based care management and operational platform. The transaction is expected to close in Q3 2023, with TIP's leadership joining ApolloMed to spearhead clinical and operational initiatives in Texas.
Apollo Medical Holdings, Inc. Receives NCQA's HEDIS Health Plan Measure Certification for Measurement Year 2023
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) announced it has received NCQA's HEDIS Health Plan Measure Certification for Measurement Year 2023, expanding its certification from 5 to 20 measures. This marks the second consecutive year the company has achieved this certification, signifying its commitment to industry-leading clinical quality measurement processes. The expanded certification covers widely used HEDIS measures in managed care, including key diabetes measures, and allows ApolloMed to offer its HEDIS engine via RESTful API to partners.
Apollo Medical Holdings, Inc. Announces APA ACO Achieved $48.8 Million in Shared Savings from Centers for Medicare and Medicaid Services for 2021 Performance Year
Apollo Medical Holdings, Inc. announced that its subsidiary, APA ACO, Inc., achieved $48.8 million in shared savings from the Centers for Medicare & Medicaid Services for the 2021 performance year. This resulted from gross savings of $56.2 million generated through its participation in the Next Generation Accountable Care Organization Model, where APA ACO took on an advanced risk-taking payment model. The company's leadership highlighted this as validation of ApolloMed's physician-centric, tech-enabled, value-based care model's effectiveness in delivering high-quality, cost-effective care.
Apollo Medical Acquires Clinics in Nevada and Texas
Apollo Medical Holdings Inc. has acquired nine primary care clinics from Valley Oaks Medical Group, expanding its presence into Nevada and Texas. The acquisition, funded by cash on hand, is expected to close by the end of the year and continues Apollo Medical's trend of expanding beyond Southern California. The company specializes in helping physician-based medical groups operate more efficiently through technology and managing insurance contracts.
Apollo Medical Holdings, Inc. Expands into Nevada and Texas with Acquisition of Valley Oaks Medical Group
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) announced its acquisition of Valley Oaks Medical Group, encompassing nine primary care clinics in Las Vegas, Houston, and Fort Worth. This acquisition marks ApolloMed's entry into operating primary care clinics in Nevada and Texas, expanding its value-based care model to new geographic markets. The transaction, funded by cash on hand, is expected to close by the end of Q4 2022 and will allow ApolloMed to serve over 20,000 patients, including Medicare members.
Apollo Medical Holdings, Inc. Announces Affiliate's Entry into Agreement to Acquire All American Medical Group and For Your Benefit
Apollo Medical Holdings, Inc. announced its affiliated California medical corporation has agreed to acquire All American Medical Group (AAMG) and For Your Benefit, Inc. (FYB), along with related managed care assets. This acquisition will expand ApolloMed's presence in Northern California by adding over 15,000 Medicare Advantage, Commercial, and Medicaid patients in the San Francisco Bay Area, bringing their total members in the region to over 30,000. The transaction, expected to close by the end of Q1 2023, aims to enhance value-based care delivery, broaden patient networks, and improve care coordination by combining ApolloMed's expertise with AAMG and FYB's community-focused care.
Apollo Medical Holdings, Inc. Announces Purchase of Controlling Interests in Sun Clinical Laboratories
Apollo Medical Holdings, Inc. (ApolloMed) announced its agreement to purchase controlling interests in Sun Clinical Laboratories (Sun Labs) for $4.0 million. This acquisition will integrate Sun Labs, a CLIA-certified full-service lab with 19 locations, into ApolloMed's value-based care delivery platform, aiming for greater operational efficiencies and expanded geographic reach. The move is also expected to leverage Sun Labs' genomic testing capabilities to enhance ApolloMed's personalized cancer care offerings.
Apollo Medical Holdings, Inc. and CAIPA MSO, LLC Announce Strategic Alliance in New York
Apollo Medical Holdings, Inc. and CAIPA MSO, LLC have announced a strategic alliance and investment by ApolloMed in CAIPA MSO, marking ApolloMed's entry into the New York market. ApolloMed will acquire 30% of CAIPA MSO, aiming to combine their population health management platform with CAIPA MSO's local experience to deliver high-quality, cost-efficient care, especially to underserved populations. This partnership is expected to empower healthcare providers and scale their services nationwide.
